These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 29212159)

  • 1. LEF1, TFE3, and AR are putative diagnostic markers of solid pseudopapillary neoplasms.
    Kim EK; Jang M; Park M; Kim H
    Oncotarget; 2017 Nov; 8(55):93404-93413. PubMed ID: 29212159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The usefulness of lymphoid enhancer-binding factor 1 and androgen receptor in diagnosing solid pseudopapillary neoplasm of the pancreas on cytopathology.
    McHugh KE; Stelow EB; Harrison GP; Policarpio-Nicolas MLC
    Cancer Cytopathol; 2019 Nov; 127(11):700-707. PubMed ID: 31584754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TFE3 is a diagnostic marker for solid pseudopapillary neoplasms of the pancreas.
    Jiang Y; Xie J; Wang B; Mu Y; Liu P
    Hum Pathol; 2018 Nov; 81():166-175. PubMed ID: 30030118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diagnostic Utility of LEF1 Immunostain in Cytology Specimens of Solid Pseudopapillary Neoplasm of Pancreas].
    Farzaneh T; Nowroozizadeh B; Han M; Lee W
    Acta Cytol; 2021; 65(3):250-256. PubMed ID: 33887729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunocytochemistry for SOX-11 and TFE3 as diagnostic markers for solid pseudopapillary neoplasms of the pancreas in FNA biopsies.
    Foo WC; Harrison G; Zhang X
    Cancer Cytopathol; 2017 Nov; 125(11):831-837. PubMed ID: 29045075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of lymphoid enhancer-binding factor 1 (LEF1) in solid-pseudopapillary neoplasms of the pancreas.
    Singhi AD; Lilo M; Hruban RH; Cressman KL; Fuhrer K; Seethala RR
    Mod Pathol; 2014 Oct; 27(10):1355-63. PubMed ID: 24658583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphoid Enhancer Binding Factor 1 (LEF1) and Paired Box Gene 8 (PAX8): A Limited Immunohistochemistry Panel to Distinguish Solid Pseudopapillary Neoplasms and Pancreatic Neuroendocrine Tumors.
    Lu H; Allende D; Liu X; Zhang Y
    Appl Immunohistochem Mol Morphol; 2020; 28(10):776-780. PubMed ID: 32723981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pancreatic neuroendocrine tumor and solid-pseudopapillary neoplasm: Key immunohistochemical profiles for differential diagnosis.
    Ohara Y; Oda T; Hashimoto S; Akashi Y; Miyamoto R; Enomoto T; Satomi K; Morishita Y; Ohkohchi N
    World J Gastroenterol; 2016 Oct; 22(38):8596-8604. PubMed ID: 27784972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of SOX11 and TFE3 in Solid-Pseudopapillary Neoplasms of the Pancreas.
    Harrison G; Hemmerich A; Guy C; Perkinson K; Fleming D; McCall S; Cardona D; Zhang X
    Am J Clin Pathol; 2017 Dec; 149(1):67-75. PubMed ID: 29272888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Solid-Pseudopapillary Neoplasm of the Pancreas: A 63-Case Analysis of Clinicopathologic and Immunohistochemical Features and Risk Factors of Malignancy.
    Chen H; Huang Y; Yang N; Yan W; Yang R; Zhang S; Yang P; Li N; Feng Z
    Cancer Manag Res; 2021; 13():3335-3343. PubMed ID: 33883945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-grade Solid Pseudopapillary Neoplasms of the Pancreas: Distinct Clinicopathological Malignant Features With Intriguing Gene Alterations through a Comparison With the Conventional Type.
    Honda S; Yamaguchi H; Aimono E; Hara S; Minamiguchi S; Norose T; Ohike N; Yamochi T; Yasuda M; Moriya T; Shiko Y; Nishihara H; Nagao T
    Am J Surg Pathol; 2024 Mar; 48(3):353-363. PubMed ID: 38189381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SCG2 and CPE may be novel markers for the identification of pancreatic neuroendocrine tumors and solid pseudopapillary neoplasms.
    Yang W; Wang S; Zhang Z; Guo H; Liu C; Zhao M; Liu Y; Peng L
    Transl Cancer Res; 2024 Jul; 13(7):3407-3417. PubMed ID: 39145076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A limited panel of INSM1 and LEF1 immunostains accurately distinguishes between pancreatic neuroendocrine tumor and solid pseudopapillary neoplasm.
    Guo W; Farzaneh T; Lee W; Nael A; Li X; Chandan VS
    Pathol Res Pract; 2021 Jul; 223():153462. PubMed ID: 34048981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathological and immunohistochemical study of 29 cases of solid-pseudopapillary neoplasms of the pancreas in patients under 20 years of age along with detailed review of literature.
    Din NU; Rahim S; Abdul-Ghafar J; Ahmed A; Ahmad Z
    Diagn Pathol; 2020 Dec; 15(1):139. PubMed ID: 33298094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pleomorphic solid pseudopapillary neoplasm of the pancreas: degenerative change rather than high-grade malignant potential.
    Kim SA; Kim MS; Kim MS; Kim SC; Choi J; Yu E; Hong SM
    Hum Pathol; 2014 Jan; 45(1):166-74. PubMed ID: 24321526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of LEF-1 immunohistochemical staining in the diagnosis of solid pseudopapillary neoplasm of the pancreas.
    Geetha SD; Khan A; Khan A; Ziemba Y; Chau K; Sham S; Sheikh-Fayyaz S; Rishi A; Savant D
    Pathol Res Pract; 2024 Nov; 263():155662. PubMed ID: 39427587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 'Microcystic pattern' should be recognised as part of the morphological spectrum of solid-pseudopapillary neoplasm of the pancreas.
    Abe A; Ohishi Y; Miyazaki T; Ozono K; Mochidome N; Saeki K; Nakamura M; Oda Y
    Histopathology; 2018 Jan; 72(2):216-226. PubMed ID: 28858381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathological analysis of β-catenin and Axin-1 in solid pseudopapillary neoplasms of the pancreas.
    Huang SC; Ng KF; Yeh TS; Chang HC; Su CY; Chen TC
    Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S438-46. PubMed ID: 21769465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. α-Methylacyl-CoA racemase (P504S) is a useful marker for the differential diagnosis of solid pseudopapillary neoplasm of the pancreas.
    Shen Y; Wang Z; Zhu J; Chen Y; Gu W; Liu Q
    Ann Diagn Pathol; 2014 Jun; 18(3):146-50. PubMed ID: 24675392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct Protein Expression Profiles of Solid-Pseudopapillary Neoplasms of the Pancreas.
    Park M; Lim JS; Lee HJ; Na K; Lee MJ; Kang CM; Paik YK; Kim H
    J Proteome Res; 2015 Aug; 14(8):3007-14. PubMed ID: 26148796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.